Skip to content

Efficacy of Xyloglucan nasal spray in allergic rhinitis children

Efficacy of Xyloglucan nasal spray in allergic rhinitis children : Prospective randomized, Double-blinded, Placebo-controlled crossover study

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240318004
Enrollment
80
Registered
2024-03-18
Start date
2023-06-16
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis in children Allergic rhinitis

Interventions

spray 2 puff each nostril 3 times a day for 2 weeks,spray 2 puff each nostril 3 times a day for 2 weeks
Active Comparator Drug,Placebo Comparator Drug
Xyloglucan spray,Placebo

Sponsors

Faculty of Medicine Ramathibodi Hospital Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Age 6-18 years, 2. Physician-diagnosed allergic rhinitis, 3. Aeroallergen sensitization, 4. Not pregnant, lactation

Exclusion criteria

Exclusion criteria: 1. Comorbid cardiovascular disease, primary immunodeficiency, 2. Active tuberculosis, 3. Airway anomalies, 4. Current immunotherapy, 5. Recent respiratory infection in 4 weeks

Design outcomes

Primary

MeasureTime frame
Rhinitis symptoms 2 months Total nasal symptoms score,Rhinitis symptoms 2 months Visual analogue scale (VAS),Rhinitis symptoms 2 months Peak nasal inspiratory flow(PNIF)

Secondary

MeasureTime frame
Safety of Xyloglucan spray 2 months Patients report in record form

Countries

Thailand

Contacts

Public ContactPiyapong Laopakorn

Faculty of Medicine Ramathibodi Hospital, Mahidol University

Ham.ham.07@hotmail.com022011760

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026